Creek, I'm no chartist, but a chart that looks like a guy having a heart attack is not healthy. You want to see price gaps filled with steady buying that replace panic selling. Small biotechs run on PR's. There is no question we will have more PR's leading up to the 2/25 divvie date, but I don't see anything that will surprise anyone.

The mo-mo guys and total amateurs will get bored and sell. Those trading around a core position will sell on rips and buy back on dips. That's the reality of stock trading. 12-18 months is a long time in stock years for the small individual investor. I agree that the pps will be above $3 by then. However, there will be many red days between now and then, and the critics will follow.

The pps may be considerably higher as the company executes. However, as they say on TV, the easy money has been made. After one reversal day on Friday we have talk of shorts and manipulation. Sounds like the old GNBT, but it isn't. This is a totally different company that was able to retain the few valuable assets of the old GNBT.

I'm not being critical of GNBT in the least. I'm just opining on the process that takes a small OTC company to becoming a mature enterprise that trades on a reputable exchange.